The DOI matches its Crossref record.
Development of a Cell-Based, High-Throughput Screening Assay for Cholesterol Efflux Using a Fluorescent Mimic of Cholesterol
Abstract
Reverse cholesterol transport is the process by which extrahepatic cells, including macrophage-derived foam cells in arterial atherosclerotic plaque, transport excessive cholesterol back to the liver for bile acid synthesis and excretion, thus lowering the peripheral lipid burden. Cholesterol efflux from peripheral cells is the first step in this process, and finding drugs and interventions that promote this event is an important endeavor. Radioisotope-labeled cholesterol traditionally has been employed in measuring efflux efficiency, but this reagent has limitations for high-throughput screening. We developed an alternative method to measure cholesterol efflux in macrophage-derived foam cells using a novel fluorescent cholesterol mimic comprising the Pennsylvania Green fluorophore, attached by a linker containing a glutamic acid residue, to a derivative of N-alkyl-3β-cholesterylamine. Compared with the traditional radioisotope-based assay, this fluorescence-based assay gave similar results in the presence of known modulators of cholesterol efflux, such as cyclic AMP, and different cholesterol acceptors. When the fluorescent probe was employed in a high-throughput screening format, a variety of chemicals and bioactive compounds with known and unknown effects on cholesterol efflux could be tested simultaneously by plate-reader in a short period of time. Treatment of THP-1-derived macrophages with inhibitors of the membrane transporter ATP-binding cassette A1, such as glyburide or a specific antibody, significantly reduced the export of this fluorescent compound, indicating that ATP-binding cassette A1 represents the primary mediator of its cellular efflux. This fluorescent mimic of cholesterol provides a safe, sensitive, and reproducible alternative to radioactive assays in efflux experiments and has great potential as a valuable tool when incorporated into a drug discovery program.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“APOE4 astrocytes also exhibited reduced cholesterol efflux in the presence of 2% HDL and the cholesterol chelator methyl-β-cyclodextrin (MBCD), a measure of the total available cholesterol in the plasma membrane using fluorescently-labeled cholesterol (Figure 6L)(Lopez et al., 2011; Zhang et al., 2011).”
From Cholesterol and matrisome pathways dysregulated in astrocytes and microglia (2022) · cites this paper as Zhang et al., 2011
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 38
- 10.1016/j.pharmthera.2006.02.003 · DOI
- 10.1161/ATVBAHA.107.158998 · DOI
- 10.1016/j.cmet.2008.03.001 · DOI · Paper page
- 10.1021/ol052655g · DOI
- 10.1021/jf051505h · DOI
- 10.1177/108705719900400206 · DOI · Paper page
- 10.3181/00379727-196-43185 · DOI
- 10.3109/09687689509038505 · DOI
- 10.1021/bi0008534 · DOI
- 10.1016/S0022-2275(20)34891-4 · DOI
- 10.1074/jbc.275.17.12769 · DOI
- 10.1002/cbf.1048 · DOI
- 10.1002/jcb.22667 · DOI
- 10.1074/jbc.M003434200 · DOI
- 10.1161/CIRCULATIONAHA.105.593855 · DOI
- 10.1152/ajpheart.01075.2008 · DOI
- 10.1016/j.bbalip.2006.09.018 · DOI
- 10.1161/01.ATV.0000235697.35431.05 · DOI
- 10.1017/BJN20061866 · DOI
- 10.1093/jn/134.11.2991 · DOI
- 10.1016/j.bbrc.2005.08.204 · DOI
- 10.1093/ajcn/85.2.385 · DOI
- 10.1161/ATVBAHA.109.187252 · DOI
- 10.1161/ATVBAHA.109.198036 · DOI
- 10.1074/jbc.271.48.30647 · DOI
- 10.1016/S1388-1981(99)00041-4 · DOI
- 10.1016/S0022-2275(20)34893-8 · DOI
- 10.1074/jbc.M003337200 · DOI
- 10.1161/01.RES.0000250171.54048.5c · DOI · Paper page
- 10.1111/j.1365-2796.2007.01898.x · DOI · Paper page
- 10.1021/bi0004192 · DOI
- 10.1194/jlr.M300358-JLR200 · DOI
- 10.1194/jlr.M600145-JLR200 · DOI
- 10.1016/j.biopha.2006.07.090 · DOI
- 10.1111/j.1471-4159.2008.05433.x · DOI
- 10.1083/jcb.200601030 · DOI
- 10.1016/j.bbrc.2008.09.009 · DOI
- 10.1042/bj2690807 · DOI
Cited by
Sorted by citations
Cholesterol and matrisome pathways dysregulated in astrocytes and microglia
TCW, J., Qian, L., Pipalia, N. H., Chao, M. J., Liang, S. A., Shi, Y., Jain, B. R., Bertelsen, S. E., Kapoor, M., Marcora, E., et al. (2022) · Cell · doi:10.1016/j.cell.2022.05.017 · Cited by 411
Determinants of cholesterol efflux capacity in humans
Talbot, C. P. J., Plat, J., Ritsch, A., & Mensink, R. P. (2018) · Progress in Lipid Research · doi:10.1016/j.plipres.2017.12.001 · Cited by 99
Metadata
- Authors
- Zhang, J., Cai, S., Peterson, B. R., Kris-Etherton, P. M., & Heuvel, J. P. V.
- Affiliations
- The Pennsylvania State University
- The University of Kansas
- Venue
- ASSAY and Drug Development Technologies
- Publisher
- SAGE Publications
- Published
- 2011-04
- Volume
- 9
- Issue
- 2
- Pages
- 136-146
- ISSN
- 1540-658X
- 1557-8127
- Cited by
- 34
- References
- 0
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review